Antimicrobial resistance (AMR) is one of the clearest threats to global health today — quietly undermining decades of medical progress by making common infections harder, costlier, and sometimes impossible to treat. Understanding what drives AMR and how communities, health systems, and policymakers can respond is essential for protecting lives and preserving the effectiveness of existing medicines.

What drives antimicrobial resistance
AMR emerges when microbes adapt to survive exposure to antimicrobial drugs. Key drivers include:
– Overuse and misuse of antibiotics in humans, such as unnecessary prescriptions for viral illnesses
– Inadequate dosing or incomplete treatment courses
– Routine use of antibiotics in agriculture for growth promotion and disease prevention
– Poor infection prevention and control in healthcare facilities and communities
– Lack of access to rapid diagnostics that distinguish bacterial from viral infections

global health image

– Environmental contamination from pharmaceutical manufacturing and wastewater

Why AMR matters
When antibiotics and other antimicrobials lose effectiveness, routine surgeries, cancer therapies, diabetes management, and childbirth become riskier. AMR increases healthcare costs through longer hospital stays and need for more expensive or toxic drugs. It also worsens health equity, hitting low-resource settings hardest where access to second-line treatments or advanced care is limited.

Practical actions that make a difference
Combating AMR requires coordinated action across sectors — a One Health approach recognizing the link between human, animal, and environmental health. Key interventions with proven impact include:

– Strengthen antibiotic stewardship: Implement prescribing guidelines, delayed-prescription strategies, and clinician education to ensure antibiotics are used only when needed and with the right drug, dose, and duration.
– Expand rapid diagnostics: Invest in affordable point-of-care tests that help clinicians distinguish bacterial from viral infections, reducing unnecessary antibiotic use.
– Improve infection prevention and control: Promote hand hygiene, vaccination, safe childbirth practices, and hospital infection control to prevent the spread of resistant pathogens.
– Reduce antibiotic use in agriculture: Phase out routine use for growth promotion, apply veterinary oversight, and adopt better husbandry practices to lower the need for medicines in livestock.
– Enhance surveillance and data sharing: Build laboratory capacity and integrated surveillance systems to track resistance patterns and guide clinical and public health decisions.
– Incentivize new treatments and tools: Create market and regulatory incentives for development of new antibiotics, alternative therapies, and rapid diagnostics, while ensuring responsible use of new products.
– Address environmental sources: Monitor and regulate pharmaceutical manufacturing discharge and improve wastewater treatment to limit environmental exposure to antimicrobials.

What individuals can do
Personal actions matter. People can protect themselves and communities by following prescribed treatment instructions, avoiding pressure on clinicians for antibiotics, staying up-to-date with recommended vaccines, practicing good hygiene, and staying informed about safe food handling.

The role of global cooperation
AMR does not respect borders; resistant pathogens can spread rapidly through travel, food supply chains, and trade. International collaboration on surveillance, stewardship standards, research funding, and equitable access to diagnostics and treatments is critical. Investment in health systems strengthening, laboratory networks, and workforce training amplifies local ability to detect and respond to resistance.

Sustaining antibiotic effectiveness requires sustained commitment across sectors and scales. By combining smarter prescribing, better diagnostics, preventive measures, and global coordination, it is possible to slow resistance and protect the medicines relied on for modern healthcare. Acting now preserves treatment options for current and future generations.